Global Vinblastinesulphate (CAS 143-67-9) Market Data Survey Report 2025
- HEY2798822
- 71 Pages
- October 2018
- Medical Devices
Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
The global Vinblastinesulphate (CAS 143-67-9) market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Fine Chemicals Corporation
Vinkem
Major applications as follows:
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Major Type as follows:
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Guangzhou Hanfang Pharmaceutical
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Hainan Vinca Biological Medicine Technology
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Guangzhou Person Pharmaceutical
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Hainan Yueyang Biotechnology
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Hubei Honch Pharmaceutical
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Fine Chemicals Corporation
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Fine Chemicals Corporation
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Vinkem
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Lymphoma
4.1.1 Overview
4.1.2 Lymphoma Market Size and Forecast
4.2 Lung Cancer
4.2.1 Overview
4.2.2 Lung Cancer Market Size and Forecast
4.3 Breast & Ovarian Cancer
4.3.1 Overview
4.3.2 Breast & Ovarian Cancer Market Size and Forecast
4.4 Leukemia
4.4.1 Overview
4.4.2 Leukemia Market Size and Forecast
4.5 Other
4.5.1 Overview
4.5.2 Other Market Size and Forecast
5 Market by Type
5.1 >98% Vinblastinesulphate
5.1.1 Overview
5.1.2 >98% Vinblastinesulphate Market Size and Forecast
5.2 97-98% Vinblastinesulphate
5.2.1 Overview
5.2.2 97-98% Vinblastinesulphate Market Size and Forecast
5.3 Other
5.3.1 Overview
5.3.2 Other Market Size and Forecast
6 Conclusion
Tab Regional Production 2012-2017 (Volume)
Tab Regional Demand and CAGR 2012-2017 (Million USD)
Tab Regional Demand and CAGR 2012-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2012-2017 (Million USD)
Tab Regional Export 2012-2017 (Volume)
Tab Regional Import 2012-2017 (Million USD)
Tab Regional Import 2012-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Guangzhou Hanfang Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Hainan Vinca Biological Medicine Technology
Tab Sales Revenue, Volume, Price, Cost and Margin of Guangzhou Person Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Hainan Yueyang Biotechnology
Tab Sales Revenue, Volume, Price, Cost and Margin of Hubei Honch Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Fine Chemicals Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Fine Chemicals Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Vinkem
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
